summa up semaglutide Novo Nordisk announced headline results from STEP UP, a phase IIIb trial investigating subcutaneous 7.2 mg for obesity Semaglutide Improves Hidradenitis Suppurativa in

Previous studies show that GLP-1 receptor agonist treatment reduced microglial activation and reverse lipopolysaccharide (LPS)-induced inflammation in the hippocampus (36,88,89), indicating that these properties are preserved in its conjugated form

F.AlleeM

[1] [2] Common GLP-1 medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), while tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist

Alexis Pedrick: Cretinism prevented people from developing physically and mentally

The practical impact is concerning: Some women have reported unexpected pregnancies while on the pill and GLP-1s together